Evidence map›Paper›PMID 31252034›Full record

ArticleThe Journal of investigative dermatology2020

Glyburide, a NLRP3 Inhibitor, Decreases Inflammatory Response and Is a Candidate to Reduce Pathology in Leishmania braziliensis Infection.

Augusto M Carvalho, Fernanda O Novais, Camilla S Paixão, Camila I de Oliveira, Paulo Roberto Lima Machado, Lucas P Carvalho, Phillip Scott, Edgar M Carvalho

Open access · bronzeAbstract readLetter
In one paragraph

Article in The Journal of investigative dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. ThePathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Review
  8. The Role of Senescent CD8Pathogens (Basel, Switzerland) · 2024
    Article
  9. Article
  10. New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Review
  11. EXCLI journal · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Prostaglandin E2 contributes toEmerging microbes & infections · 2023
    Article
  16. CCR5 promotes the migration of CD8bioRxiv : the preprint server for biology · 2023
    Article
  17. Frontiers in immunology · 2023
    Article
  18. Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  19. The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  20. Protection and Pathology inPathogens (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Augusto M CarvalhoInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil; Serviço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Fernanda O NovaisDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Camilla S PaixãoInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.
Camila I de OliveiraInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.
Paulo Roberto Lima MachadoInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil; Serviço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil; Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais (INCT-DT), Salvador, Bahia, Brazil.
Lucas P CarvalhoInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil; Serviço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil; Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais (INCT-DT), Salvador, Bahia, Brazil.
Phillip ScottDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Edgar M CarvalhoInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil; Serviço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil; Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais (INCT-DT), Salvador, Bahia, Brazil. Electronic address: imuno@ufba.br.
Universidade Federal da Bahia · BRFundação Oswaldo Cruz · BRUniversity of Pennsylvania · US

Funding

The role of Leishmania braziliensis strain polymorphism on disease outcome and ..P50AI030639 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 1991 to 2023
$9.1M
The Role of Innate Cells in the Pathogenesis of Leishmania Braziliensis InfectionU01AI088650 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, PHILLIP · 2011 to 2019
$4.3M
Inflammation in the Pathogenesis of Disseminated LeishmaniasisU01AI136032 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 2017 to 2021
$1.6M
NIAID NIH HHS P50 AI030639NIAID NIH HHS U01 AI088650NIAID NIH HHS U01 AI136032
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiopsyBrazilCells, CulturedCytokinesEndemic DiseasesGlyburideHumansHypoglycemic AgentsInflammation MediatorsLeishmania braziliensisLeishmaniasis, CutaneousMacrophagesNLR Family, Pyrin Domain-Containing 3 ProteinSkinCytokinesGlyburideHypoglycemic AgentsInflammation MediatorsNLR Family, Pyrin Domain-Containing 3 Protein

Identifiers

PMID31252034
PMCPMC7851844
OpenAlexW2953822624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.